Scholars Central

ArticlePublished 14 Mar 2024

Therapeutic Effect of Ambroxol Hydrochloride in Conjunction with Azithromycin in Treating Mycoplasma pneumoniae Pneumonia in Children

Authors: P. Li, W. Li, P. Ao, Guanwei Dong, S. Luo, Yi Luo, Z. Xiu, Danyu Yan, Hong Qaio, Demao Mao

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

To observe the therapeutic effect and changes in chest computed tomography signs in treating Mycoplasma pneumoniae pneumonia in children with ambroxol hydrochloride in conjunction with azithromycin. From November 2021 to November 2023, a total of 70 children diagnosed with Mycoplasma pneumoniae pneumonia were admitted to our hospital. These children were randomly assigned to either the control group or the observation group, with equal distribution of 35 cases in each group. Oral azithromycin was administered to the control group for 5 consecutive days, while the observation group received a combined treatment of azithromycin for 5 consecutive days and ambroxol hydrochloride for 7 consecutive days. A comparison was made between the two groups in terms of the time needed for temperature recovery, cough resolution, and disappearance of lung rales. Additionally, the comparison of various chest computed tomography signs before and after 7 d of treatment was conducted between the two groups. The incidence of adverse reactions during the treatment period was also recorded and compared. The observation group showed a remarkably shorter duration for temperature recovery, cough resolution, and disappearance of lung rales compared to the control group (p 0.05). The combination therapy of ambroxol hydrochloride and azithromycin offers substantial therapeutic benefits for treating Mycoplasma pneumoniae pneumonia in children. It effectively reduces the duration of symptoms and signs, facilitates the recovery of lung lesions, and poses no notable risk of adverse reactions.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalIndian Journal of Pharmaceutical Sciences
  • SubjectPharmaceutical Sciences
  • BylineArticles whose byline prints “P. Li”
  • BylineArticles whose byline prints “W. Li”
  • BylineArticles whose byline prints “P. Ao”
  • BylineArticles whose byline prints “Guanwei Dong”
  • BylineArticles whose byline prints “S. Luo”
  • BylineArticles whose byline prints “Yi Luo”
  • BylineArticles whose byline prints “Z. Xiu”
  • BylineArticles whose byline prints “Danyu Yan”